McCrae K, Hayashi K, Bardwell G, Nosova E, Milloy MJ, Wood E, Ti L The effect of injecting alone on the use of drug checking services among people who inject drugs Int J Drug Policy, 2020. PubMed
Lee WK, Hayashi K, DeBeck K, Milloy MJ, Grant C, Wood E, Kerr T Association between posttraumatic stress disorder and nonfatal drug overdose Psychol Trauma, 2020. PubMed
Karamouzian M, Johnson C, Kerr T Public health messaging and harm reduction in the time of COVID-19 Lancet Psychiatry, 2020. PubMed
Fairgrieve C, Nosova E, Milloy MJ, Fairbairn N, DeBeck K, Ahamad K, Wood E, Kerr T, Hayashi K Temporal changes in non-fatal opioid overdose patterns among people who use drugs in a Canadian setting Subst Abus, 2020. PubMed
Socías ME, Wood E, Dong H, Brar R, Bach P, Murphy SM, Fairbairn N Slow release oral morphine versus methadone for opioid use disorder in the fentanyl era (pRESTO): protocol for a non-inferiority randomized clinical trial Contemp Clin Trials, 2020. PubMed
Kennedy MC, Hayashi K, Milloy MJ, Boyd J, Wood E, Kerr T Supervised injection facility use and exposure to violence among a cohort of people who inject drugs: a gender-based analysis Int J Drug Policy, 2020. PubMed
Prangnell A, Shoveller J, Voon P, Shulha H, Grant C, Milloy MJ, Kerr T, Hayashi K The impact of childhood emotional abuse on pain interference among people with chronic pain who inject drugs in Vancouver, Canada Pain Med, 2020. PubMed
Boyd J, Lavalley J, Czechaczek S, Mayer S, Kerr T, Maher L, McNeil R "Bed Bugs and Beyond": an ethnographic analysis of North America's first women-only supervised drug consumption site Int J Drug Policy, 2020. PubMed
Goodyear T, Mniszak C, Jenkins E, Fast D, Knight R "Am I gonna get in trouble for acknowledging my will to be safe?": Identifying the experiences of young sexual minority men and substance use in the context of an opioid overdose crisis Harm Reduct J, 2020. PubMed
Caulfield MDG, Brar R, Sutherland C, Nolan S Transitioning a patient from injectable opioid agonist therapy to sublingual buprenorphine/naloxone for the treatment of opioid use disorder using a microdosing approach BMJ Case Rep, 2020. PubMed
